324 filings
Page 3 of 17
8-K
oumgww8
7 Jun 22
Departure of Directors or Certain Officers
4:45pm
8-K
e6k65
31 May 22
Andrew Jackson Appointed Chief Financial Officer
7:30am
8-K
ahqpr
27 May 22
Brooklyn ImmunoTherapeutics Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Quarterly Report on Form 10-Q
4:35pm
8-K
ztii0gann7p91oj2j
19 Apr 22
Changes in Registrant's Certifying Accountant
4:30pm
8-K
rmxuyu963ehjkrwfauf
15 Apr 22
Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results
5:18pm
8-K
ry4pui0t6 wo
9 Mar 22
Brooklyn ImmunoTherapeutics Announces Closing of $12 Million Private Placement
4:21pm
8-K
n91t0ty xzk0zfj
24 Jan 22
Changes in Registrant's Certifying Accountant
5:00pm
8-K
kdptt9 7kj
20 Jan 22
Departure of Directors or Certain Officers
7:40am
8-K
4a2m9ij u0qzc
5 Jan 22
Cost Associated with Exit or Disposal Activities
6:06am
8-K
tlyt 0ysb
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
gwlepeiyf6h2cvcstc
23 Nov 21
Other Events
8:00am
8-K
vvbeimql2l l1
12 Nov 21
Regulation FD Disclosure
6:05am
8-K
a9i5b5y
14 Oct 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K/A
m21t5zhugxp71nnla zl
1 Oct 21
Financial Statements and Exhibits
4:31pm
8-K
qn8ekkq7jy9s5jr24f
23 Sep 21
Changes in Registrant's Certifying Accountant
4:30pm
8-K
vzxg4rwvd 3ema
20 Sep 21
Regulation FD Disclosure
4:29pm
8-K
dku4mecdso1m
14 Sep 21
Other Events
7:00am
8-K
nxxidwx
13 Sep 21
Submission of Matters to a Vote of Security Holders
6:05am
8-K
qiqiv5deq5dc lndjhlg
9 Sep 21
Regulation FD Disclosure
6:05am
8-K
a1rytdem8by4jxg4
20 Aug 21
Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum
4:45pm